These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 1401312)
41. [Therapeutic effects of 5-florouracil ointment on various skin diseases]. Yamamoto K; Sasaki S Gan No Rinsho; 1972 Mar; 18(3):214-8. PubMed ID: 5063951 [No Abstract] [Full Text] [Related]
42. [The use of antioxidants in the combined treatment of dermatoses and skin tumors]. Verbenko EV; Ezhova MN Sov Med; 1991; (7):56-7. PubMed ID: 1948348 [No Abstract] [Full Text] [Related]
43. Intralesional and Laser-Assisted 5-Fluorouracil in Dermatologic Disease: A Systematic Review. Prince GT; Cameron MC; Fathi R; Alkousakis T J Drugs Dermatol; 2018 Mar; 17(3):274-280. PubMed ID: 29537445 [TBL] [Abstract][Full Text] [Related]
44. Therapeutic Update: Update on Cutaneous and Systemic Therapy for Primary Cutaneous T Cell Lymphoma, Mycosis Fungoides. Lo Sicco K; Latkowski JA J Drugs Dermatol; 2015 Dec; 14(12):1381-3. PubMed ID: 26659928 [No Abstract] [Full Text] [Related]
45. The therapeutic uses of topical vitamin A acid. Thomas JR; Doyle JA J Am Acad Dermatol; 1981 May; 4(5):505-13. PubMed ID: 6453882 [TBL] [Abstract][Full Text] [Related]
46. Azelaic Acid: Evidence-based Update on Mechanism of Action and Clinical Application. Schulte BC; Wu W; Rosen T J Drugs Dermatol; 2015 Sep; 14(9):964-8. PubMed ID: 26355614 [TBL] [Abstract][Full Text] [Related]
47. Photodynamic therapy in dermatology. Shedding a different light on skin disease. Lui H; Anderson RR Arch Dermatol; 1992 Dec; 128(12):1631-6. PubMed ID: 1456759 [No Abstract] [Full Text] [Related]
48. Advances in the therapeutic use of mammalian target of rapamycin (mTOR) inhibitors in dermatology. Fogel AL; Hill S; Teng JM J Am Acad Dermatol; 2015 May; 72(5):879-89. PubMed ID: 25769191 [TBL] [Abstract][Full Text] [Related]
49. [Indications of cytostatic medications in dermatology]. Mikol C Presse Med (1893); 1967 Jun; 75(28):1458. PubMed ID: 6025533 [No Abstract] [Full Text] [Related]
51. [Study and evaluation of the problems caused by topical drugs in dermatological roentgen therapy]. Miani F Minerva Dermatol; 1966 Nov; 41(11):410-4. PubMed ID: 5998032 [No Abstract] [Full Text] [Related]
52. Non-acne dermatologic indications for systemic isotretinoin. Akyol M; Ozçelik S Am J Clin Dermatol; 2005; 6(3):175-84. PubMed ID: 15943494 [TBL] [Abstract][Full Text] [Related]
53. Dermatologic therapy in the 1980s. Thiers BH Dermatol Clin; 1988 Oct; 6(4):609-25. PubMed ID: 3067919 [TBL] [Abstract][Full Text] [Related]
54. [Mechanisms of action of heparin in autoimmune and proliferative dermatoses]. Berenbeĭn BA; Verbenko EV; Karpunichev AN Vestn Dermatol Venerol; 1989; (7):15-9. PubMed ID: 2683469 [No Abstract] [Full Text] [Related]
55. Photodynamic therapy for the treatment of skin disease. Kendall CA; Morton CA Technol Cancer Res Treat; 2003 Aug; 2(4):283-8. PubMed ID: 12892510 [TBL] [Abstract][Full Text] [Related]
56. Bowenoid conditions of the skin: treatment with topical 5-fluorouracil. Jansen GT; Dillaha CJ; Honeycutt WM South Med J; 1967 Feb; 60(2):185-8. PubMed ID: 6016410 [No Abstract] [Full Text] [Related]
58. [Therapy of skin- and venereal diseases. Review of the literature 1969]. Walther H Dtsch Med J; 1970 Jun; 21(12):870-6 passim. PubMed ID: 4259633 [No Abstract] [Full Text] [Related]